Dry eye disease can be difficult to diagnose, and delays in diagnosis may lead to more severe symptoms and a greater impact on patients’ daily lives, according to a European study. Reuters Health Information
Category: News
Accelerated Crosslinking Effective for Keratoconus
Accelerated transepithelial corneal crosslinking safely and effectively treats progressive keratoconus, researchers reported. Medscape Medical News
Treating Bacterial Keratitis in Developing Countries
Povidone-iodine may be a cost-effective method for reducing corneal scarring and visual impairment in developing countries. Medscape Optometry
Pixium Vision implanta IRIS®II, su innovador sistema de visión biónica equipado con 150 electrodos, a 10 pacientes en el marco de su ensayo clínico
PARÍS–(BUSINESS WIRE)–Pixium Vision (Paris:PIX), una empresa que desarrolla y comercializa innovadores sistemas de visión biónica para dotar a las personas que han perdido la vista de mayor independencia, ha anunciado la realización de 10 implantes en el marco de su estudio IRIS® II. Todos los pacientes implantados tendrán que seguir su programa de reeducación tal y como se define en el estudio multicentro europeo en curso para IRIS® II que se lanzó en enero de 2016. Khalid Ishaque, CEO de Pi
New Vanderbilt Center offers comprehensive care for patients with Marfan syndrome and aortic disease
With the recent opening of the Vanderbilt Marfan Syndrome and Aortic Disorders Center, the state’s only comprehensive clinic serving entire families, hundreds of patients with connective tissue disorders now have a one-stop shop for health care.
Europe Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis Report 2016-2025 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Europe Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis – 2017” report to their offering. The report provides insights into Age-Related Macular Dege…
Can’t-Miss Highlights in Retina
Catch up on the latest in the diagnosis and management of vitreoretinal diseases, including some of the new and upcoming therapeutic options. Medscape Ophthalmology
Unum launches dental and vision coverage
CHATTANOOGA, Tenn.–(BUSINESS WIRE)–#Starmount–A longtime leader in employee benefits, Unum (NYSE:UNM) has entered a new arena with the launch of Unum Dental and Unum Vision.
Hormonal fluctuations make women more sensitive to addictive properties of cocaine, study reveals
Hormonal fluctuations women undergo make them particularly sensitive, compared to men, to the addictive properties of cocaine, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published January 10 in the journal Nature …
Heidelberg Engineering and Gauss Medical Corporation Establish an Ophthalmic Healthcare IT Joint Venture in China
HEIDELBERG, Germany–(BUSINESS WIRE)–Heidelberg Engineering and Gauss Medical Corporation Establish an Ophthalmic Healthcare IT Joint Venture in China
Stem cell research offers new hope of restoring sight
As the population ages, retinal degeneration becomes more prevalent. Stem cell research inches closer to a future where vision loss may be reversible.
First US Service Members Treated with the Only FDA-Approved Cross-Linking Procedure in the U.S.
WALTHAM, Mass.–(BUSINESS WIRE)–#avedro–Avedro, Inc., an ophthalmic pharmaceutical and medical device company, has begun selling Photrexa Viscous® (riboflavin 5-‘phosphate in 20% dextran ophthalmic solution), Photrexa® (riboflavin 5’-phosphate ophthalmic solution) and the KXL® System to key military hospitals around the country. Fort Belvoir Hospital, located in Fort Belvoir, VA, made history on November 21st to become the first military facility in the country to perform FDA-approved corneal cross-li
IACTA Pharmaceuticals Licenses NM133 from Nanomerics for Treatment of Dry Eye
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–IACTA Pharmaceuticals has acquired the North American rights to develop and commercialize NM133, an investigational medicine designed to help treat dry eye from its developer, Nanomerics, Ltd.
NOACs Linked to Higher Risk of Intraocular Bleeding
Some new oral anticoagulants (NOACs) are associated with an increased risk of intraocular hemorrhage, according to a new analysis of World Health Organization (WHO) data. Reuters Health Information
Electronic Record Keeping With Google Glass and Helpers
Google Glass technology used in combination with a remote scribe can help physicians keep up with federal electronic health record requirements. Could it be the stethoscope of this century? Medscape Medical News
Second Sight Medical Products, Inc. Announces Rights Offering
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (Nasdaq:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announ…
Vision symptoms following concussion limit a child’s ability to return to the classroom
A comprehensive vision assessment should be part of return-to-learn protocols to help determine when children are ready to return to the classroom following concussions – particularly in children…
FDA Clears Ranibizumab for Myopic Choroidal Neovascularization
Ranibizumab becomes the first FDA-approved anti-vascular endothelial growth factor therapy for mCNV. FDA Approvals
6 Major Advances in Ophthalmology
Take a look back at some of the top innovations that advanced the field of ophthalmology in 2016. Medscape Ophthalmology
Company Profile for EYENOSTICS
–(BUSINESS WIRE)–Eyenostics is a Contract Research Organization (CRO) dedicated to research and analysis of ocular biomarkers for clinical and preclinical studies using Flow Cytometry and RT-qPCR methods. With its experienced team of employees, partners and a renowned consultant, Eyenostics’ ambition is to become a preferred business partner for big pharmaceutical companies and biotechnology companies looking for new, relevant data for their ophthalmology studies. Eyenostics’ strength lies in